Increased serum soluble corin in dyslipidemia: A cross-sectional study

Area of Science:

• Cardiovascular Research
• Metabolic Syndrome Studies
• Biomarker Discovery

Background:

• Natriuretic peptides are linked to dyslipidemia.
• Corin, a physiological activator of natriuretic peptides, may also relate to dyslipidemia.
• This association remains unexamined in Chinese populations.

Purpose of the Study:

• To investigate the association between serum soluble corin levels and dyslipidemia.
• To evaluate corin as a potential risk factor or biomarker for dyslipidemia in a Chinese cohort.

Main Methods:

• Serum soluble corin and blood lipid profiles were measured in 2496 Chinese adults over 30 years old.
• Logistic regression analysis was employed to assess the relationship between serum soluble corin and dyslipidemia.
• Confounding factors were controlled for in the statistical model.

Main Results:

• Serum soluble corin levels were significantly elevated in participants with dyslipidemia, in both men and women.
• A positive trend was observed, with increasing corin levels correlating with a higher odds ratio for dyslipidemia.
• Individuals with high serum soluble corin exhibited a significantly increased likelihood of having dyslipidemia.

Conclusions:

• Serum soluble corin is significantly and positively associated with dyslipidemia.
• These findings suggest that serum soluble corin may serve as a valuable biomarker or risk factor for dyslipidemia.
• Further research is warranted to elucidate the underlying mechanisms and clinical implications.